O. Public Health (Issues pertaining to preparedness for and response to outbreaks including those linked to agents of bioterror, foodborne, waterborne, vector borne, zoonotic diseases, vaccine-preventable diseases and social determinants of health)
Poster Session: Public Health
Frederick Angulo, DVM PhD (he/him/his)
Lead, Scientific Affairs
Pfizer Vaccines
Portland, Oregon, United States
Emily Colby, MPH
Pfizer Vaccines
Collegeville, Pennsylvania, United States
Volker Fingerle, PhD
Ludwig-Maximilians University
Munich, Bayern, Germany
Anne-Mette Lebech, MD
University Hospital Copenhagen-Rigshospitalet
Copenhagen, Nordjylland, Denmark
Per-Eric Lindgren, MD
Linköping University
Linköping, Ostergotlands Lan, Sweden
Anna Moniuszko-Malinowska, MD
Medical University of Bialystok
Bialystok, Podlaskie, Poland
Franc Strle, MD
University of Ljubljana
Ljubljana, Ljubljana, Slovenia
Julia Olsen, MPH
Pfizer Vaccines
Collegeville, Pennsylvania, United States
Gordon Brestrich, PhD
Pfizer Vaccines
Berlin, Berlin, Germany
Andrew Vyse, Ph.D.
Pfizer UK
Tadworth, England, United Kingdom
Madiha Shafquat, MPH
Pfizer Vaccines
New York, New York, United States
L. Hannah Gould, PhD, MS, MBA
Senior Director, Global Medical and Scientific Affairs
Pfizer Vaccines
New York, New York, United States
Patrick Kelly, PhD
Pfizer Vaccines
Collegeville, Pennsylvania, United States
Andreas Pilz, PhD
Director
Pfizer Corporation Austria
Vienna, Wien, Austria
Kate Halsby, PhD
Pfizer Inc
London, England, United Kingdom
Jennifer Moisi, PhD
Pfizer Vaccines
Collegeville, Pennsylvania, United States
James H. Stark, PhD
Medical Study Lead, Senior Director
Pfizer Biopharma Group
Collegeville, Pennsylvania, United States